Elaine Dennison

Prof. Elaine Dennison

Univ Hosp Southampton, MRC Lifecourse Epidemiol Unit, Tremona Rd, Southampton SO16 6YD, Hants, UK

Research Focus & Metrics

Academic Career Length

27Years (2000-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 July 2010 in The Lancet
Verified
Journal Article
Closed access
TWThomas J Wang
Thomas J Wang
FZFeng Zhang
Feng Zhang
JRJ Brent Richards
J Brent Richards
BKBryan Kestenbaum
Bryan Kestenbaum
JMJoyce B van Meurs
Joyce B van Meurs
TSTimothy D Spector
Timothy D Spector

4 December 2014 in PLOS ONE
Verified
Journal Article
Open access
PDF file
RDRichard M Dodds
Richard M Dodds
HSHolly E Syddall
Holly E Syddall
RCRachel Cooper
Rachel Cooper
MBMichaela Benzeval
Michaela Benzeval
IDIan Deary
Ian Deary
ASAvan A. Sayer
Avan A. Sayer
Epidemiological studies have shown that weaker grip strength in later life is associated with disability, morbidity, and mortality. Grip strength is a key component of the sarcopenia and frailty phenotypes and yet it is unclear how individual measurements should be interpreted. Our objective was to produce cross-sectional centile values for grip strength across the life course. A secondary objective was to examine the impact of different aspects of measurement protocol. We combined 60,803 observations from 49,964 participants (26,687 female) of 12 general population studies in Great Britain. We produced centile curves for ages 4 to 90 and investigated the prevalence of weak grip, defined as strength at least 2.5 SDs below the gender-specific peak mean. We carried out a series of sensitivity analyses to assess the impact of dynamometer type and measurement position (seated or standing). Our results suggested three overall periods: an increase to peak in early adult life, maintenance through to midlife, and decline from midlife onwards. Males were on average stronger than females from adolescence onwards: males’ peak median grip was 51 kg between ages 29 and 39, compared to 31 kg in females between ages 26 and 42. Weak grip strength, defined as strength at least 2.5 SDs below the gender-specific peak mean, increased sharply with age, reaching a prevalence of 23% in males and 27% in females by age 80. Sensitivity analyses suggested our findings were robust to differences in dynamometer type and measurement position. This is the first study to provide normative data for grip strength across the life course. These centile values have the potential to inform the clinical assessment of grip strength which is recognised as an important part of the identification of people with sarcopenia and frailty.

20 January 2013 in British Medical Bulletin
Verified
Journal Article
Open access
PDF file
ALAnna Litwic
Anna Litwic
MEMark H. Edwards
Mark H. Edwards
EDElaine Dennison
Elaine Dennison
CCCyrus Cooper
Cyrus Cooper
Osteoarthritis (OA) is a degenerative joint disease involving the cartilage and many of its surrounding tissues. Disease progression is usually slow but can ultimately lead to joint failure with pain and disability. OA of the hips and knees tends to cause the greatest burden to the population as pain and stiffness in these large weight-bearing joints often leads to significant disability requiring surgical intervention. The article reviews the existing data on epidemiology of osteoarthritis and the burden of the disease. Symptoms and radiographic changes are poorly correlated in OA. Established risk factors include obesity, local trauma and occupation. The burden of OA is physical, psychological and socioeconomic. Available data does not allow definite conclusion regarding the roles of nutrition, smoking and sarcopenia as risk factors for developing OA. Variable methods of diagnosing osteoarthritis have significantly influenced the comparability of the available literature. Further research is required to fully understand how OA affects an individual physically and psychologically, and to determine their healthcare need.

1 December 2001 in Bone
Verified
Journal Article
Closed access
VSVictoria van Staa
Victoria van Staa
EDElaine Dennison
Elaine Dennison
HLH.G.M Leufkens
H.G.M Leufkens
CCC Cooper
C Cooper

2 April 2011 in Osteoporosis International
Verified
Journal Article
Closed access
PDF file
TEThe IOF CSA Working Group on Fracture Epidemiology
The IOF CSA Working Group on Fracture Epidemiology
CCC. Cooper
C. Cooper
ZCZ. A. Cole
Z. A. Cole
CHC. R. Holroyd
C. R. Holroyd
SES. C. Earl
S. C. Earl
JKJ. A. Kanis
J. A. Kanis

19 January 2018 in Journal of Cachexia, Sarcopenia and Muscle
Verified
Journal Article
Open access
PDF file
FBFanny Buckinx
Fanny Buckinx
FLFrancesco Landi
Francesco Landi
Matteo  CesariMatteo Cesari
Matteo Cesari
RFRoger A. Fielding
Roger A. Fielding
MVMarjolein Visser
Marjolein Visser
JKJohn A. Kanis
John A. Kanis
Background: All proposed definitions of sarcopenia include the measurement of muscle mass, but the techniques and threshold values used vary. Indeed, the literature does not establish consensus on the best technique for measuring lean body mass. Thus, the objective measurement of sarcopenia is hampered by limitations intrinsic to assessment tools. The aim of this study was to review the methods to assess muscle mass and to reach consensus on the development of a reference standard.Methods: Literature reviews were performed by members of the European Society for Clinical and Economic Aspects of Osteoporosis and Osteoarthritis working group on frailty and sarcopenia. Face‐to‐face meetings were organized for the whole group to make amendments and discuss further recommendations.Results: A wide range of techniques can be used to assess muscle mass. Cost, availability, and ease of use can determine whether the techniques are better suited to clinical practice or are more useful for research. No one technique subserves all requirements but dual energy X‐ray absorptiometry could be considered as a reference standard (but not a gold standard) for measuring muscle lean body mass.Conclusions: Based on the feasibility, accuracy, safety, and low cost, dual energy X‐ray absorptiometry can be considered as the reference standard for measuring muscle mass.